Navigation Links
MNX nomme un nouveau membre à son conseil d'administration, la société vise à accélérer sa croissance dans la logistique pour les domaines pharmaceutique et des essais cliniques
Date:6/24/2013

LOS ANGELES, 25 juin 2013 /PRNewswire/ -- MNX, un fournisseur international de services de logistique et de transport rapide, est heureux d'annoncer la nomination de Renzo DiCarlo à son conseil d'administration. Cette nomination intervient à un moment où MNX accélère sa stratégie de croissance dans le secteur des sciences de la vie en s'intéressant particulièrement à la logistique dans les domaines pharmaceutique et des essais cliniques dans les régions EMEA et Asie-Pacifique. 

(Logo : http://photos.prnewswire.com/prnh/20130624/LA36380LOGO)

M. DiCarlo travaille depuis 20 ans dans l'industrie pharmaceutique, il possède une vaste expérience de la livraison de dispositifs médicaux et de médicaments thérapeutiques homologués par la FDA. En tant que PDG de BioPharma Services, M. DiCarlo dirige une équipe de plus de 200 professionnels des sciences de la vie basée à Toronto, au Canada. La société dispose de partenaires affiliés en Europe et en Asie, elle fournit des services de recherche pour les essais cliniques (Phases I-IIa), de bioéquivalence, pharmaceutiques, de gestion des données réglementaires et statistiques à des sociétés pharmaceutiques de premier plan produisant des médicaments génériques et de marque dans le monde entier. Ses équipes sont impliquées dans la gestion de nombreuses études chaque année dans d'importants domaines de recherche, notamment l'orthopédie, la dermatologie, l'arthrite, le diabète, l'oncologie ainsi que d'autres maladies graves.

« La connaissance approfondie de l'industrie pharmaceutique de M. DiCarlo et son franc succ&#
'/>"/>

SOURCE MNX
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bausch + Lomb nomme Robert Bertolini président et directeur financier
2. Après son lancement réussiaux États-Unis, le nouveau Simbionix U/S Mentor va être présenté pour la première fois en Europe
3. RuiYi et Genor BioPharma collaborent au développement du RYI-008 en Chine, un nouveau traitement contre les maladies auto-immunes et le cancer
4. Nouveau Life Pharmaceuticals (NOUV) Releases Calcium & Vitamin D for Strong Bones
5. Nouveau Life Offers Potential Distributors Online Access to Company and Contract
6. Nouveau Life Pharmaceuticals (NOUV) Releases Krill Oil to Support Healthy Cholesterol Levels and Reduce Inflammation
7. The Facelift Alternative by Nouveau Contour
8. Nouveau Life Pharmaceuticals (NOUV) Launches Affiliate Sales Program
9. Nouveau Life Pharmaceuticals (NOUV) In Talks with International Mass Distribution Firms
10. Nouveau Life Pharmaceuticals (NOUV) to Launch Affiliate Sales Program
11. Nouveau Life Pharmaceuticals (NOUV) to Begin Sales of Azul Instant™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014  As the Medical Affairs, role has become ... this area are exploring methods to develop strong capabilities ... Consortium at Best Practices, LLC is designed to give ... the key challenges they face. The consortium will provide ... virtual roundtable discussions where leaders discuss key findings from ...
(Date:8/22/2014)... Ohio , Aug. 22, 2014 MC Medical, ... Inc. (MID), a Columbus, OH medical ... distribute the FloShield laparoscopic and robotic visualization system in ... be approved for sale in Japan ... a long-time experience and an extensive product portfolio in endoscopic ...
(Date:8/22/2014)... Aug. 22, 2014  Research presented at the 29 th ... developed by Hera Therapeutics Inc. combats three types of human ... cervical cancer. When tested in several cultured human ... HPV-11 cells, according to Louise T. Chow , Ph.D. ... at the Seattle conference. The National ...
Breaking Medicine Technology:Best Practices' Medical Affairs Consortium Survey Has Achieved Strong Participation 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2
... KALAMAZOO, Mich., Sept. 9 Global Pharmaceutical Services ... the worldwide pharmaceutical and biotechnology industry announces a new clinical ... has entered into an exclusive partnership with Abridge Clinical Research ... India. "We are delighted in working with such an experienced ...
... , IRVINE, Calif., Sept. 8 ... U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ... ocular itching associated with allergic conjunctivitis in patients two years of ... new, safe and effective way to treat the itching caused by ...
Cached Medicine Technology:Life Sciences Company Opens Clinical Trial Bridge to India 2ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 2ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 3ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 4ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 5
(Date:8/22/2014)... Penn Medicine team has found that targeted automated ... tract infections in hospital patients with urinary catheters. ... was simplified, the rate of improvement dramatically increased. ... patients need urinary catheters in the first place ... for catheters that have not been removed within ...
(Date:8/22/2014)... Natural Clear Vision , a how-to guide ... vision from legally blind to perfect 20/20 vision has caught ... , “There is a huge portion of the population today ... most people just think that’s the way it will always ... be pretty risky at times,” reports Michaels. “This program is ...
(Date:8/22/2014)... Epidermal growth factor receptor (EGFR) mutations found in the ... advanced non-small cell lung cancer (NSCLC) patients correlates well ... , EGFR tyrosine kinase inhibitor (TKI) therapy is approved ... but the standard for determining mutation status is with ... limited or not available. A more abundant and less ...
(Date:8/22/2014)... York, New York (PRWEB) August 22, 2014 ... continue to be filed in U.S. courts on ... events due to their use of prescription low ... court documents, a new claim was filed against ... man who allegedly suffered life-threatening heart issues due ...
(Date:8/22/2014)... FRIDAY, Aug. 22, 2014 (HealthDay News) -- An intensive effort ... to an animal shelter in Florida and euthanized, a new ... enough cats to slow their intake into animal control," Dr. ... of Florida College of Veterinary Medicine, said in a university ... there wasn,t making a big impact," she explained, "so we ...
Breaking Medicine News(10 mins):Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Neutering Project Curbed Feral Cat Population 2
... Pharmacopeia,(Nasdaq: PCOP ), an innovator in ... today announced that it has licensed from,Bristol-Myers Squibb ... modulator,(SARM) program, including a lead compound in Phase ... non-steroidal selective androgen,receptor modulator, or SARM, which was ...
... Ill. A study published in the October ... (JCSM) finds that modafinil is well-tolerated in the treatment ... wakefulness such as shift work sleep disorder, obstructive sleep ... or sleep parameters. , The study, authored by Thomas ...
... 15 With school schedules now routine and,the initial ... again",sighs. This might be a good time to re-evaluate ... http://www.newscom.com/cgi-bin/prnh/20071015/NYFNSL01 ) The following are suggestions ... and snacks for greater nutritional impact. Add a,handful of ...
... - ,Real Women, Real Pain, Campaign Highlights ... in Women Around the World Today, the International ... the Global Year Against Pain in Women to draw ... and the need for more,effective care. Lack of awareness ...
... A new study by Rhode Island Hospital and Brown University ... surgery did not receive the initial psychiatric clearance for the ... of decisions to clear candidates for surgery, and the largest ... and detail the reasons for exclusion. It was published in ...
... Attention-deficit/hyperactivity disorder (ADHD), a state of serious impairments in ... many labels for one of the most prevalent conditions ... partly persists into adulthood. ADHD is conservatively estimated to ... 1998), but more permissive criteria yield estimates of up ...
Cached Medicine News:Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 2Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 3Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 4Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 5Health News:Study: Modafinil is effective in treating excessive sleepiness 2Health News:Fresh, Tasty - Healthy - Lunch and Snack Ideas 2Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 2Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 3Health News:1 in 5 bariatric surgery candidates not psychologically cleared for surgery 2Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 2Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 3
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
This optimal design addresses low-cost, simple, non-invasive ankle distraction....
... BTA stat Test is an ... qualitative detection of bladder tumor ... with bladder cancer. This test ... aid in the management of ...
... TheraTears Liquid Gel is a thicker version ... or for those who need a longer-lasting ... Liquid Gel is so long-lasting, it is ... preserved gels, there never needs to be ...
Medicine Products: